Ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate (Compound)

Synonyms:ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate, SMR000496762, MLS000998839, MLS004820109, CHEMBL1536119, SCHEMBL16322777, US10064853, Compound 1, BDBM271332, HMS2820I09, s2846, NCGC00386827-01, MS-27296, HY-114086, CS-0064985, BRD-K20754212-001-11-4, BRD-K20754212-001-12-2

Pubchem:PUBCHEM:23723882

Id:a28da8cd-2f33-5057-98a6-05b64a62cd0c

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate.

Results found

Linked to

	Label	Description
	BRD-K20754212-001-12-2 Substance (Entity type)	A Substance
	Ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate bioactivity Protein disulfide-isomerase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

BRD-K20754212-001-12-2

Substance (Entity type)

A Substance

Ethyl 1-(3-chloro-4-hydroxybenzyl)-4-(2-phenoxyethyl)piperidine-4-carboxylate bioactivity Protein disulfide-isomerase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.